Evidence map›Paper›PMID 34100189›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.

Poulomee Bose, Elsa Tremblay, Claudia Maios, Vijay Narasimhan, Gary A B Armstrong, Meijiang Liao, J Alex Parker, Richard Robitaille, Xiao Yan Wen, Christopher Barden and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Unraveling Molecular Targets for Neurodegenerative Diseases ThroughInternational journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Poulomee BoseDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada.
Elsa TremblayDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada.
Claudia MaiosCentre de Recherche du Centre Hospitalier de L'Université de Montréal (CRCHUM Tour Viger R09-482), 900 Rue Saint Denis, Montréal, Quebec, H2X 0A9, Canada.
Vijay NarasimhanZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital and Department of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada.
Gary A B ArmstrongDepartment of Neurology and Neurosurgery, McGill University and Montreal Neurological Institute, Montreal, Canada.
Meijiang LiaoDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada.
J Alex ParkerDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada.
Richard RobitailleDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada.
Xiao Yan WenZebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital and Department of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada.
Christopher BardenTreventis Corporation, 60 Leonard Avenue, Toronto, Ontario, Canada.
Pierre DrapeauDepartment of Neuroscience, Université de Montréal, Montréal, Quebec, Canada. p.drapeau@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34100189
PMCPMC8609081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.